Carregant...
One year survivor of metastatic renal cell carcinoma treated with pazopanib
Tyrosine kinase inhibitor (TKI) and its side effects are well known. However, these are mainly descriptive, with pictorial data lacking. Here, in we report a case of metastatic renal cell carcinoma, treated with TKI, with classic side effects; supplemented with images that demonstrate the adverse ef...
Guardat en:
| Publicat a: | Urol Ann |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5405669/ https://ncbi.nlm.nih.gov/pubmed/28479777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-7796.204178 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|